|
|
 |
On June 12 the Community Research Initiative on AIDS (CRIA), located in New York City, announced that it will begin two studies of metabolic disorders (fat redistribution, and blood sugar
abnormalities) now being recognized more frequently in some persons with AIDS.
The first study will follow 30 people for three months when they begin HIV treatment with protease inhibitors. Using a modified oral glucose tolerance test, the study will look for changes in the
volunteers' ability to process sugar. A different study will examine the safety and effectiveness of using human growth hormone to treat abnormal fat redistribution-- whether or not the volunteers are also on protease-inhibitor treatment.
These studies are expected to begin in early July; to find out about volunteering, call the Community Research Initiative on AIDS, 212-924-3934.
Editor's Note: from AIDS Treatment News
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
